Effect of Piracetam on attention deficit and hyperactivity disorder

Abstract

The effect of Piracetam on attention deficit and hyperactivity disorder (ADHD) was studied on 25 children with developmental delay in placebo-controlled cross over study. Placebo or piracetam as suspension was administered to the children 50 mg/kg/day in 3 divided doses for a period of 3 weeks. After a wash out period of 2 weeks the treatment was resumed reversely. ADHD was induced and increased in the group taking piracetam significantly more than in the placebo group (P<0.05). Thus, piracetam in children with developmental delay induces and increases ADHD and should be taken cautiously